home / stock / valn / valn articles
The FDA approved Valneva SE's (NASDAQ: VALN) Chikungunya single-dose vaccine in individuals aged 18 and above. The company plans...
Saint-Herblain (France), November 7, 2023 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced that its senior ma...
Saint Herblain (France), September 25, 2023 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced the signing of a...
Saint-Herblain (France), August 31, 2023 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced that members of its...
News, Short Squeeze, Breakout and More Instantly...
Valneva SE Company Name:
VALN Stock Symbol:
NASDAQ Market:
Monday, Valneva SE (NASDAQ:VALN) released further Phase 3 data in adolescents for its single-shot chikungunya virus (CHIKV) vaccine....
2024-05-05 02:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-25 08:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...